ClinicalTrials.Veeva

Menu

Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis

N

Naval Military Medical University

Status

Enrolling

Conditions

Chronic Pancreatitis
Pancreatic Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06411470
CHEC2024-149

Details and patient eligibility

About

The investigators plan to collect throat swabs, saliva, feces and serum samples from pancreatic cancer patients, chronic pancreatitis patients and healthy people and clarify the characteristics of oral flora and serum metabolome of pancreatic cancer patients.

Enrollment

600 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

1.Pathologic diagnosis of pancreatic ductal adenocarcinoma;Diagnosis of CP defined as having obvious morphological features of CP (i.e., the presence of pancreatic calcifications on CT scan and/or magnetic resonance cholangiopancreatography);Other benign disease populations without pancreatic lesions.

Exclusion criteria

  1. Pregnant women.
  2. Patients with coagulation disorders who are unable to undergo blood tests.
  3. Have a history of using antibiotics or probiotics within the past 3 months.

Trial design

600 participants in 3 patient groups

pancreatic cancer
Description:
Pathologic diagnosis of pancreatic ductal adenocarcinoma
chronic pancreatitis
Description:
Diagnosis of CP defined as having obvious morphological features of CP (i.e., the presence of pancreatic calcifications on CT scan and/or magnetic resonance cholangiopancreatography)
healthy people
Description:
Other benign disease populations without pancreatic lesions

Trial contacts and locations

1

Loading...

Central trial contact

Xiangyu Kong, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems